Laboratory Investigation
United States and Canadian Academy of Pathology The United States and Canadian Academy of Pathology
LWW Lippincott Williams and Wilkins
publishes Laboratory Investigation
--
                                      View Future Titles
Through Mar 2001
       Archives
Aug 1965 - Feb 2001
       Search Articles
Aug 1965 - Feb 2001
       Browse by Subject
Aug 1965 - Feb 2001
                      
Instructions to authors

Subscriptions

About the journal
   
  E-selectin Expression and Stimulation by Inflammatory Mediators are Developmentally Regulated during Embryogenesis
Editorial board

Email alerts

'Net Tips

Help

Feedback

Guestbook








  David S. Milstone, Peter E. O'Donnell, George Stavrakis, Richard M. Mortensen, and Vannessa M. Davis
   
  Vascular Research Division (DSM, PEO, GS, VMD), Department of Pathology, and Endocrine-Hypertension Division (RMM), Department of Medicine, Brigham and Women's Hospital, and Department of Pathology, Harvard Medical School, Boston, Massachusetts
   
 

SUMMARY:

Leukocyte recruitment during inflammation is specified, in part, by the spatial distribution and temporal regulation of endothelial adhesion molecules. In this study we investigated the developmental onset of E-selectin and intercellular adhesion molecule-1 (ICAM-1) basal expression and inducibility by inflammatory mediators as indices of lineage-restricted endothelial adhesion molecule expression. We studied both murine embryos and embryoid bodies (EB), derived from differentiated embryonic stem cells, to examine a broad range of endothelial ontogeny. Our results reveal that E-selectin and ICAM-1 are differentially regulated during development and that three stages define the ontogeny of the E-selectin-inducible response. The earliest endothelial lineage cells in Day 4 and Day 5 EB did not express E-selectin in the basal state or after stimulation. A second stage, observed between embryonic Day 9.5 (E9.5) and E11.5 to E12.5 in cultured embryo cells and transiently at Day 6 of EB differentiation, was characterized by basal expression that was not stimulated by inflammatory mediators. A third stage was characterized by both basal and inducible expression of E-selectin and was observed beginning at E12.5 to E13.5 in cultured embryo cells and at Day 7 in EB. In contrast ICAM-1 was stimulated at all of the embryonic stages examined and before the onset of E-selectin inducibility in both embryos and EB. E-selectin expression in embryos was also stimulated by introducing endotoxin into the embryonic, but not the maternal, peritoneum. This suggests that embryos are protected from inflammatory insults present in the maternal circulation. The developmentally regulated acquisition of E-selectin inducibility during embryogenesis likely involves changes in signal transduction cascades, transcription factors, and/or chromatin accessibility that specify inducible expression within the endothelial lineage and further restrict inducibility to particular endothelial subpopulations.